Terms: = Kidney tumors AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
5 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature.
Mei YH; Yu JP; Li G
Medicine (Baltimore); 2017 Feb; 96(6):e6092. PubMed ID: 28178171
[TBL] [Abstract] [Full Text] [Related]
3. Levels of circulating cd45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B
Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843
[TBL] [Abstract] [Full Text] [Related]
4. A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses.
O'Malley RL; Berger AD; Kanofsky JA; Phillips CK; Stifelman M; Taneja SS
BJU Int; 2007 Feb; 99(2):395-8. PubMed ID: 17092288
[TBL] [Abstract] [Full Text] [Related]
5. [A clinicopathological study of clear cell sarcoma of the kidney].
He L; Fu L; Wang L; Li P; Lang Z
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):422-5. PubMed ID: 11866983
[TBL] [Abstract] [Full Text] [Related]
